We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-14.56%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$688M
AUM Growth
-$52M
Cap. Flow
-$219M
Cap. Flow %
-31.89%
Top 10 Hldgs %
65.57%
Holding
231
New
46
Increased
68
Reduced
48
Closed
44

Top Buys

Rank Stock Value
1
AIOS
AIOS Tech
AIOS
+$28.5M
2
AGMH icon
AGM Group Holdings
AGMH
+$13.2M
3
OG
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
+$7.66M
4
ESPR
Esperion Therapeutics
ESPR
+$7.53M
5
CNTX icon
Context Therapeutics
CNTX
+$6.14M

Top Sells

Rank Stock Value
1
ZNB
Zeta Network Group
ZNB
+$3.39M
2
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$3.33M
3
TCDA
Tricida, Inc. Common Stock
TCDA
+$3.06M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$2.84M
5
FLUX icon
Flux Power
FLUX
+$2.59M

Sector Composition

Rank Sector Weight
1 Healthcare 7.43%
2 Technology 5.89%
3 Financials 5.84%
4 Consumer Discretionary 1.07%
5 Industrials 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PDSB icon
126
PUT
PDS Biotechnology
PDSB
$39.1M
$305K 0.04%
376
+92
+32% +$990
KUST
127
PUT
Kustom Entertainment Inc
KUST
$740K
– –
0
– –
BEATW icon
128
Heartbeam Inc Warrant
BEATW
$44K
$270K 0.04%
+360,391
New +$359K
RKDA icon
129
Arcadia Biosciences
RKDA
$1.38M
$263K 0.04%
+6,330
New +$413K
CBAT icon
130
CBAK Energy Technology Ltd
CBAT
$43.9M
$262K 0.04%
167,774
+150,226
+856% +$310K
DXR icon
131
Daxor
DXR
$61.5M
$237K 0.03%
20,996
-36,928
-64% -$407K
LSTA icon
132
PUT
Lisata Therapeutics
LSTA
$9.38M
$225K 0.03%
178
-246
-58% -$3.8K
CTRM icon
133
PUT
Castor Maritime
CTRM
$18.9M
$193K 0.03%
136
-125
-48% -$2.57K
NMTR
134
CALL
DELISTED
9 Meters Biopharma
NMTR
$192K 0.03%
98
-85
-46% -$1.9K
CRDL
135
Cardiol Therapeutics
CRDL
$139M
$184K 0.03%
+99,440
New +$275K
ADTX
136
PUT
DELISTED
ADITXT INC
ADTX
– –
0
– –
XELA
137
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$182K 0.03%
+52
New +$305K
HMCOW
138
DELISTED
HumanCo Acquisition Corp. Warrant
HMCOW
$176K 0.03%
200,314
– –
ZVRA icon
139
Zevra Therapeutics
ZVRA
$570M
$174K 0.03%
20,000
-21,531
-52% -$192K
HCDIP
140
DELISTED
Harbor Custom Development, Inc. 8.0% Series A Cumulative Convertible Preferred Stock, no par value
HCDIP
– –
0
– –
ORIO
141
PUT
Orion Digital Corp
ORIO
$15.2M
$167K 0.02%
163
-1,672
-91% -$24.1K
PMCB icon
142
PUT
PharmaCyte Biotech
PMCB
$6.44M
$166K 0.02%
665
+224
+51% +$617
SBEV.WS
143
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$156K 0.02%
503,266
-102,393
-17% -$40K
GFAI icon
144
Guardforce AI
GFAI
$9.69M
$136K 0.02%
3,147
-15,044
-83% -$1.25M
CTXR icon
145
PUT
Citius Pharmaceuticals
CTXR
$17.4M
$129K 0.02%
34
+14
+70% +$635
GLBS icon
146
PUT
Globus Maritime Ltd
GLBS
$63.9M
$128K 0.02%
608
-651
-52% -$1.74K
SRGA
147
PUT
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$127K 0.02%
59
– –
NMRD
148
PUT
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$125K 0.02%
275
-1,043
-79% -$5.62K
BBLGW
149
Bone Biologics Corp Warrants
BBLGW
$116K 0.02%
+5,516
New +$138K
PMCB icon
150
CALL
PharmaCyte Biotech
PMCB
$6.44M
$108K 0.02%
+431
New +$1.19K
4 5
6
7 8

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AB
Aozora Bank Tokyo, Japan $43.6M AUM 1.15% 1-Year Est. Return

Sabby Management's Q4 2021 Portfolio in Review

As of Q4 2021, Sabby Management held 231 positions worth $688M, down 7% from $740M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Sabby Management withdrew a net $219M in Q4 2021, closing 44 positions and reducing 48 holdings. Its most notable exit was Tricida, Inc. Common Stock, an estimated $3.06M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.4% of assets, up from 6.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Sabby Management opened a new position in AIOS Tech worth $10.4M.

  • Sabby Management's largest Q4 2021 buy was AIOS Tech: 16,134 shares worth $10.4M.
  • Sabby Management added most to Acutus Medical Inc in Q4 2021, an estimated $3.52M increase.
  • Sabby Management's biggest Q4 2021 reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, cutting an estimated $3.33M.
  • Sabby Management fully exited Tricida, Inc. Common Stock in Q4 2021, selling an estimated $3.06M.
  • Sabby Management's ten largest holdings make up 66% of its $688M portfolio in Q4 2021.
  • Sabby Management opened 46 new positions and closed 44 in Q4 2021.
  • Sabby Management's portfolio value fell 7% quarter-over-quarter to $688M.

Based on Sabby Management's 13F filing for Q4 2021, filed 14 Feb 2022.